Navigation Links
LASIK Retreatment Forceps

ProductsLASIK Retreatment Forceps
Company Khosla Medical & Surgical, Inc.
Item LASIK Retreatment Forceps
Features 
Description LASIK Retreatment Forceps - Also available in Titanium
Info Khosla Medical & Surgical, Inc.
Customer Service: (408) 996 0205
Web site: http://www.khosla-med.com/

Related medicine products :

1. BD Visitec LASIK Cannulas
2. BD Visitec LASIK Spears
3. BD Visitec LASIK Re-Positioners
4. Luminary™ LASIK Light Probe
5. Siepser Luminary LASIK Light Probe
6. LASIK Spear Kit
7. CleanField LASIK Kit
8. LASIK Corneal Shield
9. Yavitz LASIK Drainage Ring and Flap Cover
10. LASIK Flap Irrigator
11. LASIK Irrigator
...rade; POLYSORB™ Soft Tissue Anchor 2 mm is a...ue to bone using sutures. The resorbable repair de..., and is used to reattach damaged soft tissue. The..., derived from glycolide and lactide colored with ...
This type of anchor is generally used when anchor size may be an issue. This 2.9mm anchor is packaged sterile and comes pre-loaded with sutures (1-0 or 2-0) and needles. Although pre-drilling is not
...nerally utilized when a surgeon would like to impa... seat the anchor below the 10-12 placement of the ... same as what comes with the Collared design, the ... to easier gauge anchor depth during insertion. Th...
...rade; Ogden™ Non-Sterile Anchor is a nonabso... using sutures. The device is implanted into a pre...aged soft tissue. The anchors are manufactured fro...M (F136-92). The anchors are coated with Titanium ...
Medicine Products:
(Date:5/16/2008)... the aftermath of central China,s,earthquake, up t...es, and,over 150,000 were injured. An estimated 10... who have lost their homes. With great sorrow for,...ter Ching Hai donated an,additional US$30,000, for...reme Master Ching Hai International Association me...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...SNewswire/ -- This release is,being sent in a soci...h the,National Cancer Institute, part of the NIH.,...rican Society of Clinical,Oncology meeting in Chic...e,in about 25 percent of patients with colon cance... colorectal cancers will be staged., * This new s...
(Date:5/16/2008)...can Society of Clinical Oncology meeting in Chicag...in about 25 percent of patients with colon cancer ...olorectal cancers will be staged. , This new s...opulation-based statistic registries from 1992 to ...t outcomes of patients with positive nodes (Stage ...
Breaking Medicine News(10 mins):Health News:Supreme Master Ching Hai International Association Delivering US$160,000 in Aid to Earthquake Survivors in China 2Health News:New Method Proposed for Determining Which Patients Should Get Treatment for Colorectal Cancer 2
...nd only to smoking as a risk factor for mortality....ry disease and heart attacks increases. Healthy lu... losing lung function by 1 percent every year afte... the National Institute of Environmental Health Sc...
...me adolescents experience depression could be abno... teenagers tend to have a smaller hippocampus -- t...ing, emotion and motivation. Researchers sampled n...18, half of who had been diagnosed with major depr...
...king increases the risk of dementia , some find li...ondition, // and others still find no association ...men and women between the ages of 65 and 79 who we...eported frequent drinking in middle age (defined a...
...e their breast cancer detected by a mammogram are ...r parts of the body.// Researchers studied more th...er 9.5 years ago. Results of the study show women...s had a better disease-free survival than women wh...
Other Medicine News:
(Date:5/15/2008)...Newswire/ -- Ergonex Pharma today,announced that t...) has,granted orphan drug designation to Terguride...ion (PAH). Terguride is currently being evaluated ...The FDA,s grant of orphan drug designation to Terg...opment program by offering regulatory,clinical de...
(Date:5/15/2008)...wswire/ -- Tigris Pharmaceuticals,Inc. announced ...Development Agreement (CRADA) with the National Ca...d preclinical development of AFP-464, an,aminoflav...onverted to,metabolites which bind covalently to D...his is part of a four-year CRADA encompassing mult...
(Date:5/15/2008)...n Antiplatelet Therapy that, Combined, with Aspiri...avix/Iscover and Aspirin, According to a New R...y 15 /- Decision Resources, one of th...pharmaceutical and,healthcare issues, finds that D...nt in patient compared to Sanofi-Aventis/Bristol M...
(Date:5/15/2008)...A Trial data reports in third quarter ...RNewswire-FirstCall/ -- VIA Pharmaceuticals,Inc. ...on the development of,compounds for the treatment ... has completed patient enrollment in its acute cor...f three Phase 2 trials investigating VIA-2291,the...
Breaking Medicine Technology:Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 1New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 2New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 3New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 4New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 6New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 1090 7Insmed Receives FDA Orphan Drug Designation for IPLEX 28TM 29 in the Treatment of Myotonic Muscular Dystrophy 1085 1Insmed Receives FDA Orphan Drug Designation for IPLEX 28TM 29 in the Treatment of Myotonic Muscular Dystrophy 1085 2Insmed Receives FDA Orphan Drug Designation for IPLEX 28TM 29 in the Treatment of Myotonic Muscular Dystrophy 1085 3Creative work has health advantages Population Research Center study shows 8445 1Creative work has health advantages Population Research Center study shows 8445 2Study links success of invasive Argentine ants to diet shifts 1637 1Study links success of invasive Argentine ants to diet shifts 1637 2Study links success of invasive Argentine ants to diet shifts 1637 3